MRVL — Marvel Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Marvel Biosciences, fiscal year end - July 31st, CAD millions except per share, conversion factor applied.

	2020 July 31st	2021 July 31st	2022 July 31st	2023 July 31st	2024 July 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	0.406	2.39	0.593	0.557	0.346
Net Total Receivables	0.001	0.059	0.056	0.082	0.116
Prepaid Expenses
Total Current Assets	0.407	2.47	0.914	0.672	0.491
Net Property, Plant And Equipment	—	0	0	—	—
Total Assets	0.407	2.47	0.914	0.672	0.491
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.003	0.112	0.718	1.39	1.61
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	0.003	0.112	0.718	2.39	3.32
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	0.404	2.36	0.196	-1.72	-2.83
Total Liabilities & Shareholders' Equity	0.407	2.47	0.914	0.672	0.491
Total Common Shares Outstanding